Where should analgesia lead to? Quality of life and functional recovery with tapentadol

• Main Authors: Panella L, Rinonapoli G, Coaccioli S
• Format: Article
• Language: English
• Published: Dove Medical Press 2019-05-01
• Series: Journal of Pain Research
• Subjects: pain; quality of life; tapentadol
• Online Access: https://www.dovepress.com/where-should-analgesia-lead-to-quality-of-life-and-functional-recovery-peer-reviewed-article-JPR

Lorenzo Panella,1 Giuseppe Rinonapoli,2 Stefano Coaccioli31Rehabilitation Department, ASST Pini-CTO, 20100 Milan, Italy; 2Dipartimento di Scienze Chirurgiche, s.c. Ortopedia e Traumatologia Università di Perugia. Ospedale S.Maria della Misericordia, 06100 Perugia, Italy; 3Department of Medicine, Sezione di Clinica Medica e Anatomia Patologia, 05100 Terni, ItalyAbstract: Chronic pain is a major health-care problem worldwide, affecting more than one out of five adults in Europe. Although multiple analgesic agents have been extensively investigated in terms of clinical response and tolerability profile, few studies have focused on the impact of these therapies on patients’ quality of life (QoL). Of note, improvement in QoL, together with functional recovery, has been recognized since the late 1990s as two main goals of analgesic therapy. Tapentadol is a novel analgesic molecule that synergistically combines two mechanisms of action, μ-opioid receptor agonism and norepinephrine reuptake inhibition, and for which multiple literature data are available that confirm its efficacy and safety in controlling pain. This narrative review summarizes the information available on the impact of tapentadol on QoL, with the aim to provide clinicians with a comprehensive overview of the analgesic effects of tapentadol prolonged release beyond the reduction of pain.Keywords: pain, quality of life, tapentadol